Health Care & Life Sciences » Pharmaceuticals | Roopa Industries Ltd.

Roopa Industries Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
319,562.90
284,946.10
309,776.40
306,017.60
299,418.90
189,374.70
Cost of Goods Sold (COGS) incl. D&A
296,152.00
278,219.70
280,944.80
309,160.00
260,827.20
205,442.10
Gross Income
23,410.90
6,726.40
28,831.60
3,142.40
38,591.60
16,067.40
SG&A Expense
13,733.50
15,655.50
12,723.70
10,514.30
14,576.90
13,927.80
EBIT
9,097.80
8,389.10
15,949.50
13,841.20
23,860.60
31,514.10
Unusual Expense
447.20
85.30
1,431.20
-
6,282.90
-
Non Operating Income/Expense
2,470.30
640.60
64.20
30,154.80
74.40
44,698.50
Interest Expense
4,047.10
12,241.90
13,467.40
14,593.60
13,719.70
9,342.10
Pretax Income
3,023.20
19,463.20
1,770.40
2,644.20
4,466.40
4,410.30
Income Tax
1,271.20
605.30
158.10
929.50
799.30
984.30
Consolidated Net Income
1,752.00
20,068.50
1,612.30
1,714.60
3,667.10
5,394.60
Net Income
1,752.00
20,068.50
1,612.30
1,714.60
3,667.10
5,394.60
Net Income After Extraordinaries
1,752.00
20,068.50
1,612.30
1,714.60
3,667.10
5,394.60
Net Income Available to Common
1,752.00
20,068.50
1,612.30
1,714.60
3,667.10
5,394.60
EPS (Basic)
0.22
2.55
0.20
0.22
0.47
0.69
Basic Shares Outstanding
7,855.80
7,865.50
7,865.50
7,865.50
7,865.50
7,865.50
EPS (Diluted)
0.22
2.55
0.20
0.22
0.47
0.69
Diluted Shares Outstanding
7,855.80
7,865.50
7,865.50
7,865.50
7,865.50
7,865.50
EBITDA
14,768.50
2,487.20
21,230.60
8,642.00
28,979.30
26,266.30
Other Operating Expense
579.50
540.00
158.30
184.50
154.10
1,518.90
Non-Operating Interest Income
890.00
441.90
655.30
924.20
534.10
568

About Roopa Industries

View Profile
Address
6-2-1012, 3rd floor, TGV Mansion
Hyderabad TS 500004
India
Employees -
Website http://www.roopaindustries.com
Updated 07/08/2019
Roopa Industries Ltd. manufactures pharmaceutical products. It operates under the Manufacturing and Marketing of bulk drugs and intermediaries segment. Its products include triphenyl phosphine, glucosamine, bromine and its derivatives, esomeprazole magnesium trihydrate, and tamsulosin.